Metraipolis › archive › dc_7ffef2817cae

Extracellular Vesicles as Enabling Biomarkers for New Approach Methodologies to Support the US Food and Drug Administration Modernization Act 3.0 — Europe PMC PMID:42209425

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42209425
DOI: 10.1002/jev2.70313
License (as archived): solo-consultazione
Archived: 2026-10-08T01:14:35.684Z
SHA-256 of the archived text: 33d9553ac6fc6a83ca599a3f04ef0e377ce43e95a5d68b3cd6f911c223d7be41
Stable URL of this page: https://metraipolis.com/documento/dc_7ffef2817cae

How to cite

Extracellular Vesicles as Enabling Biomarkers for New Approach Methodologies to Support the US Food and Drug Administration Modernization Act 3.0 — Europe PMC PMID:42209425 — Europe PMC (en), https://europepmc.org/article/MED/42209425 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ffef2817cae (Metraipolis archive dc_7ffef2817cae, sha256 33d9553ac6fc6a83ca599a3f04ef0e377ce43e95a5d68b3cd6f911c223d7be41)

BibTeX

@misc{dc7ffef2817cae,
  title = {Extracellular Vesicles as Enabling Biomarkers for New Approach Methodologies to Support the US Food and Drug Administration Modernization Act 3.0 — Europe PMC PMID:42209425},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42209425},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ffef2817cae; sha256 33d9553ac6fc6a83ca599a3f04ef0e377ce43e95a5d68b3cd6f911c223d7be41},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42209425. Agents can read the archived copy with the MCP tool read_document.